360 related articles for article (PubMed ID: 32879947)
1. Prediction of survival of patients in cardiogenic shock treated by surgically implanted Impella 5+ short-term left ventricular assist device.
Nersesian G; Tschöpe C; Spillmann F; Gromann T; Roehrich L; Mueller M; Mulzer J; Starck C; Falk V; Schoenrath F; Potapov E
Interact Cardiovasc Thorac Surg; 2020 Oct; 31(4):475-482. PubMed ID: 32879947
[TBL] [Abstract][Full Text] [Related]
2. Percutaneous left-ventricular support with the Impella-2.5-assist device in acute cardiogenic shock: results of the Impella-EUROSHOCK-registry.
Lauten A; Engström AE; Jung C; Empen K; Erne P; Cook S; Windecker S; Bergmann MW; Klingenberg R; Lüscher TF; Haude M; Rulands D; Butter C; Ullman B; Hellgren L; Modena MG; Pedrazzini G; Henriques JP; Figulla HR; Ferrari M
Circ Heart Fail; 2013 Jan; 6(1):23-30. PubMed ID: 23212552
[TBL] [Abstract][Full Text] [Related]
3. Short-term mechanical circulatory support with the Impella 5.0 device for cardiogenic shock at La Pitié-Salpêtrière.
Mastroianni C; Bouabdallaoui N; Leprince P; Lebreton G
Eur Heart J Acute Cardiovasc Care; 2017 Feb; 6(1):87-92. PubMed ID: 26873912
[TBL] [Abstract][Full Text] [Related]
4. Outcome of the impella device for acute mechanical circulatory support.
Lemaire A; Anderson MB; Prendergast T; Stockmaster N; Goodman A; Lozane AM; Batsides G
Innovations (Phila); 2013; 8(1):12-6. PubMed ID: 23571788
[TBL] [Abstract][Full Text] [Related]
5. Real-life use of left ventricular circulatory support with Impella in cardiogenic shock after acute myocardial infarction: 12 years AMC experience.
Ouweneel DM; de Brabander J; Karami M; Sjauw KD; Engström AE; Vis MM; Wykrzykowska JJ; Beijk MA; Koch KT; Baan J; de Winter RJ; Piek JJ; Lagrand WK; Cherpanath TG; Driessen AH; Cocchieri R; de Mol BA; Tijssen JG; Henriques JP
Eur Heart J Acute Cardiovasc Care; 2019 Jun; 8(4):338-349. PubMed ID: 30403366
[TBL] [Abstract][Full Text] [Related]
6. Single-centre experience with the Impella CP, 5.0 and RP in 109 consecutive patients with profound cardiogenic shock.
Jensen PB; Kann SH; Veien KT; Møller-Helgestad OK; Dahl JS; Rud CS; Jensen MK; Jensen LO; Schmidt H; Møller JE
Eur Heart J Acute Cardiovasc Care; 2018 Feb; 7(1):53-61. PubMed ID: 29148290
[TBL] [Abstract][Full Text] [Related]
7. Clinical Indications of IMPELLA Short-Term Mechanical Circulatory Support in a Tertiary Centre.
Monteagudo Vela M; Simon A; Riesgo Gil F; Rosenberg A; Dalby M; Kabir T; García Saez D; Panoulas V
Cardiovasc Revasc Med; 2020 May; 21(5):629-637. PubMed ID: 31859100
[TBL] [Abstract][Full Text] [Related]
8. Impella Support for Acute Myocardial Infarction Complicated by Cardiogenic Shock.
Schrage B; Ibrahim K; Loehn T; Werner N; Sinning JM; Pappalardo F; Pieri M; Skurk C; Lauten A; Landmesser U; Westenfeld R; Horn P; Pauschinger M; Eckner D; Twerenbold R; Nordbeck P; Salinger T; Abel P; Empen K; Busch MC; Felix SB; Sieweke JT; Møller JE; Pareek N; Hill J; MacCarthy P; Bergmann MW; Henriques JPS; Möbius-Winkler S; Schulze PC; Ouarrak T; Zeymer U; Schneider S; Blankenberg S; Thiele H; Schäfer A; Westermann D
Circulation; 2019 Mar; 139(10):1249-1258. PubMed ID: 30586755
[TBL] [Abstract][Full Text] [Related]
9. The Impella device for acute mechanical circulatory support in patients in cardiogenic shock.
Lemaire A; Anderson MB; Lee LY; Scholz P; Prendergast T; Goodman A; Lozano AM; Spotnitz A; Batsides G
Ann Thorac Surg; 2014 Jan; 97(1):133-8. PubMed ID: 24090575
[TBL] [Abstract][Full Text] [Related]
10. Management and outcome of patients supported with Impella 5.0 for refractory cardiogenic shock.
Gaudard P; Mourad M; Eliet J; Zeroual N; Culas G; Rouvière P; Albat B; Colson P
Crit Care; 2015 Oct; 19():363. PubMed ID: 26453047
[TBL] [Abstract][Full Text] [Related]
11. Predictors of survival and ability to wean from short-term mechanical circulatory support device following acute myocardial infarction complicated by cardiogenic shock.
Garan AR; Eckhardt C; Takeda K; Topkara VK; Clerkin K; Fried J; Masoumi A; Demmer RT; Trinh P; Yuzefpolskaya M; Naka Y; Burkhoff D; Kirtane A; Colombo PC; Takayama H
Eur Heart J Acute Cardiovasc Care; 2018 Dec; 7(8):755-765. PubMed ID: 29094607
[TBL] [Abstract][Full Text] [Related]
12. Acute Biventricular Mechanical Circulatory Support for Cardiogenic Shock.
Kuchibhotla S; Esposito ML; Breton C; Pedicini R; Mullin A; O'Kelly R; Anderson M; Morris DL; Batsides G; Ramzy D; Grise M; Pham DT; Kapur NK
J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29054842
[TBL] [Abstract][Full Text] [Related]
13. Bridge to durable left ventricular assist device for refractory cardiogenic shock.
Yoshioka D; Takayama H; Garan AR; Topkara VK; Han J; Li B; Kurlansky P; Yuzefpolskaya M; Colombo PC; Naka Y; Takeda K
J Thorac Cardiovasc Surg; 2017 Apr; 153(4):752-762.e5. PubMed ID: 27988030
[TBL] [Abstract][Full Text] [Related]
14. Short-term mechanical circulatory support as a bridge to durable left ventricular assist device implantation in refractory cardiogenic shock: a systematic review and meta-analysis.
den Uil CA; Akin S; Jewbali LS; Dos Reis Miranda D; Brugts JJ; Constantinescu AA; Kappetein AP; Caliskan K
Eur J Cardiothorac Surg; 2017 Jul; 52(1):14-25. PubMed ID: 28472406
[TBL] [Abstract][Full Text] [Related]
15. Impella 5.0 Support in INTERMACS II Cardiogenic Shock Patients Using Right and Left Axillary Artery Access.
Schibilsky D; Lausberg H; Haller C; Lenglinger M; Woernle B; Haeberle H; Rosenberger P; Walker T; Schlensak C
Artif Organs; 2015 Aug; 39(8):660-3. PubMed ID: 26147682
[TBL] [Abstract][Full Text] [Related]
16. The role of the axillary Impella 5.0 device on patients with acute cardiogenic shock.
Tarabichi S; Ikegami H; Russo MJ; Lee LY; Lemaire A
J Cardiothorac Surg; 2020 Aug; 15(1):218. PubMed ID: 32795321
[TBL] [Abstract][Full Text] [Related]
17. Hemodynamic support with Impella ventricular assist device in patients undergoing TAVI: A single center experience.
Almalla M; Kersten A; Altiok E; Marx N; Schröder JW
Catheter Cardiovasc Interv; 2020 Feb; 95(3):357-362. PubMed ID: 31268621
[TBL] [Abstract][Full Text] [Related]
18. Mechanical circulatory support with the Impella 5.0 device for postcardiotomy cardiogenic shock: a three-center experience.
Engström AE; Granfeldt H; Seybold-Epting W; Dahm M; Cocchieri R; Driessen AH; Sjauw KD; Vis MM; Baan J; Koch KT; De Jong M; Lagrand WK; Van Der Sloot JA; Tijssen JG; De Winter RJ; De Mol BA; Piek JJ; Henriques JP
Minerva Cardioangiol; 2013 Oct; 61(5):539-46. PubMed ID: 24096248
[TBL] [Abstract][Full Text] [Related]
19. Device profile of the Impella 5.0 and 5.5 system for mechanical circulatory support for patients with cardiogenic shock: overview of its safety and efficacy.
Pahuja M; Hernandez-Montfort J; Whitehead EH; Kawabori M; Kapur NK
Expert Rev Med Devices; 2022 Jan; 19(1):1-10. PubMed ID: 34894975
[TBL] [Abstract][Full Text] [Related]
20. A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction.
Seyfarth M; Sibbing D; Bauer I; Fröhlich G; Bott-Flügel L; Byrne R; Dirschinger J; Kastrati A; Schömig A
J Am Coll Cardiol; 2008 Nov; 52(19):1584-8. PubMed ID: 19007597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
